The Cancer Letter

Inside information on cancer research and drug development

ClinicalTrials & Tribulations

Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

For many women, a confirmation of pregnancy tends to evoke numerous emotions: excitement, shock, nervousness, joy, gratitude, and sometimes, even surprise. It is a moment dreamed, prayed, and planned for—but not for all.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Narjust Florez, MD
Associate director of the Cancer Care Equity Program, Thoracic medical oncologist, Dana-Farber Cancer Institute; Assistant professor of medicine, Harvard Medical School; Associate editor, JAMA Oncology
Lauren Keil
Senior research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Rebekah Kaufman, MSc
Research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Oyepeju Abioye-Akintola, MD, MSc
Research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

Cancer History ProjectGuest Editorial

At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
By Katerina A. Politi and Roy S. Herbst
Byline
Narjust Florez, MD
Associate director of the Cancer Care Equity Program, Thoracic medical oncologist, Dana-Farber Cancer Institute; Assistant professor of medicine, Harvard Medical School; Associate editor, JAMA Oncology
Lauren Keil
Senior research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Rebekah Kaufman, MSc
Research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Oyepeju Abioye-Akintola, MD, MSc
Research assistant, Florez Laboratory, Dana-Farber Cancer Institute
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account